Texas Instruments Incorporated (TXN)
Official siteTECHNOLOGY • SEMICONDUCTORS • NASDAQ
Market Cap: $277.42B
Last updated: Nov 17, 2026 at 11:06 AM ET
Texas Instruments Incorporated (TXN) Stock Forecast
Analysts expect Texas Instruments (TXN) to earn $9.06 per share in the fiscal year ending Dec 31, 2026, on revenue of $22.40B. Of 35 analysts, 20 rate the stock Buy or Strong Buy, 13 Hold and 2 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 23 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 35 ratings average 2.43, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 57% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 5.7% |
| Buy | 18 | 51.4% |
| Hold | 13 | 37.1% |
| Sell | 2 | 5.7% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 35
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 27.8% and revenue estimates rise 17.3%.
- Fiscal year ending Dec 31, 2026
- $9.06
- EPS consensus, revenue $22.40B
- Fiscal year ending Dec 31, 2027
- $11.58
- EPS consensus, revenue $26.28B
- Next report
- Jan 25, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $9.06 | $8.55 to $9.19 | 27 | $22.40B | $22.00B to $22.49B | 28 |
| Dec 31, 2027 | $11.58 | $9.79 to $13.50 | 27 | $26.28B | $25.04B to $28.80B | 31 |
Quarterly Estimates
The EPS consensus falls from $2.65 for the quarter ending Dec 31, 2026 to $2.62 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.65 | $2.26 to $2.84 | 29 | $6.11B | $5.58B to $6.46B | 29 |
| Mar 31, 2027 | $2.62 | $2.29 to $2.88 | 22 | $6.10B | $5.58B to $6.49B | 23 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 44 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 23 | 0 |
| Quarter ending Mar 31, 2027 | 21 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 6.6% from $8.50.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $9.06 | $9.06 | $8.50 | $8.51 | $8.50 | +6.5% |
| Fiscal year ending Dec 31, 2027 | $11.58 | $11.55 | $10.13 | $10.10 | $10.03 | +15.4% |
| Quarter ending Mar 31, 2027 | $2.62 | $2.27 | $2.26 | $2.26 | $2.26 | +15.7% |
Frequently Asked Questions About TXN
What is the TXN stock forecast?
Consensus analyst estimates put Texas Instruments's EPS at $9.06 for the fiscal year ending Dec 31, 2026, on revenue of $22.40B. The consensus rating from 35 analysts is Buy.
How do analysts rate TXN stock?
Of 35 analysts covering Texas Instruments, 2 rate it Strong Buy, 18 Buy, 13 Hold, 2 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from TXN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $9.06, with estimates from $8.55 to $9.19 from 27 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $11.58, with estimates from $9.79 to $13.50 from 27 analysts.
What revenue do analysts expect from Texas Instruments next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $22.40B, with estimates from $22.00B to $22.49B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $26.28B, with estimates from $25.04B to $28.80B.
How many analysts cover TXN?
35 analysts rate Texas Instruments stock, and 27 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
TXN pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors